Search

Your search keyword '"Solit, David B"' showing total 2,030 results
Start Over Author "Solit, David B"
2,030 results on '"Solit, David B"'

101. Data from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer

Author

Maron, Steven B., primary, Chatila, Walid, primary, Walch, Henry, primary, Chou, Joanne F., primary, Ceglia, Nicholas, primary, Ptashkin, Ryan, primary, Do, Richard Kinh Gian, primary, Paroder, Viktoriya, primary, Pandit-Taskar, Neeta, primary, Lewis, Jason S., primary, Biachi De Castria, Tiago, primary, Sabwa, Shalom, primary, Socolow, Fiona, primary, Feder, Lara, primary, Thomas, Jasmine, primary, Schulze, Isabell, primary, Kim, Kwanghee, primary, Elzein, Arijh, primary, Bojilova, Viktoria, primary, Zatzman, Matthew, primary, Bhanot, Umesh, primary, Nagy, Rebecca J., primary, Lee, Jeeyun, primary, Simmons, Marc, primary, Segal, Michal, primary, Ku, Geoffrey Yuyat, primary, Ilson, David H., primary, Capanu, Marinela, primary, Hechtman, Jaclyn F., primary, Merghoub, Taha, primary, Shah, Sohrab, primary, Schultz, Nikolaus, primary, Solit, David B., primary, and Janjigian, Yelena Y., primary

Published
2023
Full Text
View/download PDF

102. Supplementary Data S1 from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer

Author

Maron, Steven B., primary, Chatila, Walid, primary, Walch, Henry, primary, Chou, Joanne F., primary, Ceglia, Nicholas, primary, Ptashkin, Ryan, primary, Do, Richard Kinh Gian, primary, Paroder, Viktoriya, primary, Pandit-Taskar, Neeta, primary, Lewis, Jason S., primary, Biachi De Castria, Tiago, primary, Sabwa, Shalom, primary, Socolow, Fiona, primary, Feder, Lara, primary, Thomas, Jasmine, primary, Schulze, Isabell, primary, Kim, Kwanghee, primary, Elzein, Arijh, primary, Bojilova, Viktoria, primary, Zatzman, Matthew, primary, Bhanot, Umesh, primary, Nagy, Rebecca J., primary, Lee, Jeeyun, primary, Simmons, Marc, primary, Segal, Michal, primary, Ku, Geoffrey Yuyat, primary, Ilson, David H., primary, Capanu, Marinela, primary, Hechtman, Jaclyn F., primary, Merghoub, Taha, primary, Shah, Sohrab, primary, Schultz, Nikolaus, primary, Solit, David B., primary, and Janjigian, Yelena Y., primary

Published
2023
Full Text
View/download PDF

103. Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Author

Friedman, Claire F., primary, Ravichandran, Vignesh, additional, Miller, Kathryn, additional, Vanderbilt, Chad, additional, Zhou, Qin, additional, Iasonos, Alexia, additional, Vivek, Malavika, additional, Mishra, Pamela, additional, Leitao, Mario M., additional, Broach, Vance A., additional, Sonoda, Yukio, additional, Kyi, Chrisann, additional, Zamarin, Dmitriy, additional, O'Cearbhaill, Roisin E., additional, Konner, Jason, additional, Berger, Michael F., additional, Weigelt, Britta, additional, Momeni Boroujeni, Amir, additional, Park, Kay J., additional, Aghajanian, Carol, additional, Solit, David B., additional, and Donoghue, Mark T.A., additional

Published
2023
Full Text
View/download PDF

104. Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Author

Valero, Cristina, primary, Golkaram, Mahdi, additional, Vos, Joris L., additional, Xu, Bin, additional, Fitzgerald, Conall, additional, Lee, Mark, additional, Kaplan, Shannon K., additional, Han, Catherine Y, additional, Pei, Xin, additional, Sarkar, Reith, additional, Boe, Lillian A., additional, Pandey, Abhinav, additional, Koh, Elizabeth S., additional, Zuur, Charlotte L., additional, Solit, David B., additional, Pawlowski, Traci, additional, Liu, Li, additional, Ho, Alan L., additional, Chowell, Diego, additional, Riaz, Nadeem, additional, Chan, Timothy A., additional, and Morris, Luc G.T., additional

Published
2023
Full Text
View/download PDF

105. Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer

Author

Maron, Steven B., primary, Chatila, Walid, additional, Walch, Henry, additional, Chou, Joanne F., additional, Ceglia, Nicholas, additional, Ptashkin, Ryan, additional, Do, Richard Kinh Gian, additional, Paroder, Viktoriya, additional, Pandit-Taskar, Neeta, additional, Lewis, Jason S., additional, Biachi De Castria, Tiago, additional, Sabwa, Shalom, additional, Socolow, Fiona, additional, Feder, Lara, additional, Thomas, Jasmine, additional, Schulze, Isabell, additional, Kim, Kwanghee, additional, Elzein, Arijh, additional, Bojilova, Viktoria, additional, Zatzman, Matthew, additional, Bhanot, Umesh, additional, Nagy, Rebecca J., additional, Lee, Jeeyun, additional, Simmons, Marc, additional, Segal, Michal, additional, Ku, Geoffrey Yuyat, additional, Ilson, David H., additional, Capanu, Marinela, additional, Hechtman, Jaclyn F., additional, Merghoub, Taha, additional, Shah, Sohrab, additional, Schultz, Nikolaus, additional, Solit, David B., additional, and Janjigian, Yelena Y., additional

Published
2023
Full Text
View/download PDF

106. Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

107. Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

108. Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

109. Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

110. Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

111. Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

112. Supplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

113. Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

114. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

Author

Doe-Tetteh, Seyram A., primary, Camp, Sabrina Y., primary, Reales, Dalicia, primary, Crowdis, Jett, primary, Noronha, Anne Marie, primary, Wolff, Bernadette, primary, Alano, Tina, primary, Galle, Jesse, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Socci, Nicholas D., primary, Liu, Ying L., primary, Tew, William P., primary, Aghajanian, Carol, primary, Ladanyi, Marc, primary, He, Meng Xiao, primary, AlDubayan, Saud H., primary, Mazor, Roei David, primary, Shpilberg, Ofer, primary, Hershkovitz-Rokah, Oshrat, primary, Riancho, Jose A., primary, Hernandez, Jose L., primary, Gonzalez-Vela, M. Carmen, primary, Buthorn, Justin J., primary, Wilson, Manda, primary, Webber, Amy E., primary, Yabe, Mariko, primary, Petrova-Drus, Kseniya, primary, Rosenblum, Marc, primary, Durham, Benjamin H., primary, Abdel-Wahab, Omar, primary, Berger, Michael F., primary, Donoghue, Mark T.A., primary, Kung, Andrew L., primary, Glade Bender, Julia, primary, Shukla, Neerav N., primary, Funt, Samuel A., primary, Dogan, Ahmet, primary, Soslow, Robert A., primary, Al-Ahmadie, Hikmat, primary, Feldman, Darren R., primary, Van Allen, Eliezer M., primary, Diamond, Eli L., primary, and Solit, David B., primary

Published
2023
Full Text
View/download PDF

115. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

Author

Doe-Tetteh, Seyram A., primary, Camp, Sabrina Y., primary, Reales, Dalicia, primary, Crowdis, Jett, primary, Noronha, Anne Marie, primary, Wolff, Bernadette, primary, Alano, Tina, primary, Galle, Jesse, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Socci, Nicholas D., primary, Liu, Ying L., primary, Tew, William P., primary, Aghajanian, Carol, primary, Ladanyi, Marc, primary, He, Meng Xiao, primary, AlDubayan, Saud H., primary, Mazor, Roei David, primary, Shpilberg, Ofer, primary, Hershkovitz-Rokah, Oshrat, primary, Riancho, Jose A., primary, Hernandez, Jose L., primary, Gonzalez-Vela, M. Carmen, primary, Buthorn, Justin J., primary, Wilson, Manda, primary, Webber, Amy E., primary, Yabe, Mariko, primary, Petrova-Drus, Kseniya, primary, Rosenblum, Marc, primary, Durham, Benjamin H., primary, Abdel-Wahab, Omar, primary, Berger, Michael F., primary, Donoghue, Mark T.A., primary, Kung, Andrew L., primary, Glade Bender, Julia, primary, Shukla, Neerav N., primary, Funt, Samuel A., primary, Dogan, Ahmet, primary, Soslow, Robert A., primary, Al-Ahmadie, Hikmat, primary, Feldman, Darren R., primary, Van Allen, Eliezer M., primary, Diamond, Eli L., primary, and Solit, David B., primary

Published
2023
Full Text
View/download PDF

116. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

Author

Doe-Tetteh, Seyram A., primary, Camp, Sabrina Y., primary, Reales, Dalicia, primary, Crowdis, Jett, primary, Noronha, Anne Marie, primary, Wolff, Bernadette, primary, Alano, Tina, primary, Galle, Jesse, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Socci, Nicholas D., primary, Liu, Ying L., primary, Tew, William P., primary, Aghajanian, Carol, primary, Ladanyi, Marc, primary, He, Meng Xiao, primary, AlDubayan, Saud H., primary, Mazor, Roei David, primary, Shpilberg, Ofer, primary, Hershkovitz-Rokah, Oshrat, primary, Riancho, Jose A., primary, Hernandez, Jose L., primary, Gonzalez-Vela, M. Carmen, primary, Buthorn, Justin J., primary, Wilson, Manda, primary, Webber, Amy E., primary, Yabe, Mariko, primary, Petrova-Drus, Kseniya, primary, Rosenblum, Marc, primary, Durham, Benjamin H., primary, Abdel-Wahab, Omar, primary, Berger, Michael F., primary, Donoghue, Mark T.A., primary, Kung, Andrew L., primary, Glade Bender, Julia, primary, Shukla, Neerav N., primary, Funt, Samuel A., primary, Dogan, Ahmet, primary, Soslow, Robert A., primary, Al-Ahmadie, Hikmat, primary, Feldman, Darren R., primary, Van Allen, Eliezer M., primary, Diamond, Eli L., primary, and Solit, David B., primary

Published
2023
Full Text
View/download PDF

118. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

Author

Pietzak, Eugene J., Bagrodia, Aditya, Cha, Eugene K., Drill, Esther N., Iyer, Gopa, Isharwal, Sumit, Ostrovnaya, Irina, Baez, Priscilla, Li, Qiang, Berger, Michael F., Zehir, Ahmet, Schultz, Nikolaus, Rosenberg, Jonathan E., Bajorin, Dean F., Dalbagni, Guido, Al-Ahmadie, Hikmat, Solit, David B., and Bochner, Bernard H.

Published
2017
Full Text
View/download PDF

119. Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

Author

Garrido-Castro, Ana C., Saura, Cristina, Barroso-Sousa, Romualdo, Guo, Hao, Ciruelos, Eva, Bermejo, Begoña, Gavilá, Joaquin, Serra, Violeta, Prat, Aleix, Paré, Laia, Céliz, Pamela, Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L., Krop, Ian E., Solit, David B., Mills, Gordon B., Cantley, Lewis C., Winer, Eric P., Lin, Nancy U., and Rodon, Jordi

Published
2020
Full Text
View/download PDF

120. Protein-altering germline mutations implicate novel genes related to lung cancer development

Author

Ji, Xuemei, Mukherjee, Semanti, Landi, Maria Teresa, Bosse, Yohan, Joubert, Philippe, Zhu, Dakai, Gorlov, Ivan, Xiao, Xiangjun, Han, Younghun, Gorlova, Olga, Hung, Rayjean J., Brhane, Yonathan, Carreras-Torres, Robert, Christiani, David C., Caporaso, Neil, Johansson, Mattias, Liu, Geoffrey, Bojesen, Stig E., Le Marchand, Loic, Albanes, Demetrios, Bickeböller, Heike, Aldrich, Melinda C., Bush, William S., Tardon, Adonina, Rennert, Gad, Chen, Chu, Byun, Jinyoung, Dragnev, Konstantin H., Field, John K., Kiemeney, Lambertus FA., Lazarus, Philip, Zienolddiny, Shan, Lam, Stephen, Schabath, Matthew B., Andrew, Angeline S., Bertazzi, Pier A., Pesatori, Angela C., Diao, Nancy, Su, Li, Song, Lei, Zhang, Ruyang, Leighl, Natasha, Johansen, Jakob S., Mellemgaard, Anders, Saliba, Walid, Haiman, Christopher, Wilkens, Lynne, Fernandez-Somoano, Ana, Fernandez-Tardon, Guillermo, Heijden, Erik H. F. M. van der, Kim, Jin Hee, Davies, Michael P. A., Marcus, Michael W., Brunnström, Hans, Manjer, Jonas, Melander, Olle, Muller, David C., Overvad, Kim, Trichopoulou, Antonia, Tumino, Rosario, Goodman, Gary E., Cox, Angela, Taylor, Fiona, Woll, Penella, Wichmann, Erich, Muley, Thomas, Risch, Angela, Rosenberger, Albert, Grankvist, Kjell, Johansson, Mikael, Shepherd, Frances, Tsao, Ming-Sound, Arnold, Susanne M., Haura, Eric B., Bolca, Ciprian, Holcatova, Ivana, Janout, Vladimir, Kontic, Milica, Lissowska, Jolanta, Mukeria, Anush, Ognjanovic, Simona, Orlowski, Tadeusz M., Scelo, Ghislaine, Swiatkowska, Beata, Zaridze, David, Bakke, Per, Skaug, Vidar, Butler, Lesley M., Offit, Kenneth, Srinivasan, Preethi, Bandlamudi, Chaitanya, Hellmann, Matthew D., Solit, David B., Robson, Mark E., Rudin, Charles M., Stadler, Zsofia K., Taylor, Barry S., Berger, Michael F., Houlston, Richard, McLaughlin, John, Stevens, Victoria, Nickle, David C., Obeidat, Ma’en, Timens, Wim, Artigas, María Soler, Shete, Sanjay, Brenner, Hermann, Chanock, Stephen, Brennan, Paul, McKay, James D., and Amos, Christopher I.

Published
2020
Full Text
View/download PDF

121. Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.

Author

Walmsley, Charlotte S., Jonsson, Philip, Cheng, Michael L., McBride, Sean, Kaeser, Christopher, Vargas, Herbert Alberto, Laudone, Vincent, Taylor, Barry S., Kappagantula, Rajya, Baez, Priscilla, Richards, Allison L., Noronha, Anne Marie, Perera, Dilmi, Berger, Michael, Solit, David B., Iacobuzio-Donahue, Christine A., Scher, Howard I., Donoghue, Mark T. A., Abida, Wassim, and Schram, Alison M.

Subjects
POLY ADP ribose, PROSTATE cancer, CONVERGENT evolution, POLY(ADP-ribose) polymerase, CASTRATION-resistant prostate cancer, BRCA genes, CELL-free DNA
Abstract

Reversion mutations that restore wild-type function of the BRCA gene have been described as a key mechanism of resistance to Poly(ADP-ribose) polymerase (PARP) inhibitor therapy in BRCA-associated cancers. Here, we report a case of a patient with metastatic castration-resistant prostate cancer (mCRPC) with a germline BRCA2 mutation who developed acquired resistance to PARP inhibition. Extensive genomic interrogation of cell-free DNA (cfDNA) and tissue at baseline, post-progression, and postmortem revealed ten unique BRCA2 reversion mutations across ten sites. While several of the reversion mutations were private to a specific site, nine out of ten tumors contained at least one mutation, suggesting a powerful clonal selection for reversion mutations in the presence of therapeutic pressure by PARP inhibition. Variable cfDNA shed was seen across tumor sites, emphasizing a potential shortcoming of cfDNA monitoring for PARPi resistance. This report provides a genomic portrait of the temporal and spatial heterogeneity of prostate cancer under the selective pressure of a PARP inhibition and exposes limitations in the current strategies for detection of reversion mutations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

123. HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes.

Author

Shah, Neil J., Aggen, David H, Zheng, Junting, Niederhausern, Andrew, Alam, Syed Muneeb, Balar, Om, Bahadur, Nadia, Watson, Adam, Regazzi, Ashley M., Ratna, Neha, Funt, Samuel A, Teo, Min Yuen, Pietzak, Eugene J., Solit, David B., Bajorin, Dean F., Philip, John, Rosenberg, Jonathan E., Ostrovnaya, Irina, Al-Ahmadie, Hikmat A., and Iyer, Gopa

Published
2024
Full Text
View/download PDF

124. HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer.

Author

Aggen, David H, Shah, Neil J., Zheng, Junting, Alam, Syed Muneeb, Balar, Om, Niederhausern, Andrew, Regazzi, Ashley M., Ratna, Neha, Funt, Samuel A, Teo, Min Yuen, Pietzak, Eugene J., Solit, David B., Bajorin, Dean F., Ostrovnaya, Irina, Rosenberg, Jonathan E., Al-Ahmadie, Hikmat A., and Iyer, Gopa

Published
2024
Full Text
View/download PDF

125. Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma.

Author

Alam, Syed Muneeb, Teo, Min Yuen, Woo, Jun, Sarfaty, Michal, Funt, Samuel A, Aggen, David H, Lee, Chung-Han, Carlo, Marie Isabel, Gandhi, Jatin, Ratna, Neha, Regazzi, Ashley M., Donoghue, Mark, Bajorin, Dean F., Coleman, Jonathan, Rosenberg, Jonathan E., Al-Ahmadie, Hikmat A., Solit, David B., and Iyer, Gopa

Published
2024
Full Text
View/download PDF

127. PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies

Author

Reis, Henning, Serrette, Rene, Posada, Jennifer, Lu, Vincent, Chen, Ying-bei, Gopalan, Anuradha, Fine, Samson W., Tickoo, Satish K., Sirintrapun, Sahussapont J., Iyer, Gopa, Funt, Samuel A., Teo, Min Yuen, Rosenberg, Jonathan E., Bajorin, Dean F., Dalbagni, Guido, Bochner, Bernard H., Solit, David B., Reuter, Victor E., and Al-Ahmadie, Hikmat A.

Published
2019
Full Text
View/download PDF

128. TNFR2/14-3-3[epsilon] signaling complex instructs macrophage plasticity in inflammation and autoimmunity

Author

Fu, Wenyu, Hu, Wenhuo, Yi, Young-Su, Hettinghouse, Aubryanna, Sun, Guodong, Bi, Yufei, He, Wenjun, Zhang, Lei, Gao, Guanmin, Liu, Jody, Toyo-oka, Kazuhito, Xiao, Guozhi, Solit, David B., Loke, Png, and Liu, Chuan-ju

Subjects
Autoimmunity -- Genetic aspects -- Health aspects, Cytokine receptors -- Genetic aspects -- Health aspects, Tumor necrosis factor -- Health aspects -- Genetic aspects, Cellular signal transduction -- Genetic aspects -- Health aspects, Macrophages -- Genetic aspects -- Physiological aspects, Rheumatoid arthritis -- Development and progression -- Genetic aspects, Health care industry
Abstract

TNFR1 and TNFR2 have received prominent attention because of their dominance in the pathogenesis of inflammation and autoimmunity. TNFR1 has been extensively studied and primarily mediates inflammation. TNFR2 remains far less studied, although emerging evidence demonstrates that TNFR2 plays an antiinflammatory and immunoregulatory role in various conditions and diseases. Herein, we report that TNFR2 regulates macrophage polarization, a highly dynamic process controlled by largely unidentified intracellular regulators. Using biochemical copurification and mass spectrometry approaches, we isolated the signaling molecule 14-3-3[epsilon] as a component of TNFR2 complexes in response to progranulin stimulation in macrophages. In addition, 14-3-3[epsilon] was essential for TNFR2 signaling-mediated regulation of macrophage polarization and switch. Both global and myeloid-specific deletion of 14-3-3[epsilon] resulted in exacerbated inflammatory arthritis and counteracted the protective effects of progranulin-mediated TNFR2 activation against inflammation and autoimmunity. TNFR2/14-3-3[epsilon] signaled through PI3K/Akt/mTOR to restrict NF-[kappa]B activation while simultaneously stimulating C/EBP[beta] activation, thereby instructing macrophage plasticity. Collectively, this study identifies 14-3-3[epsilon] as a previously unrecognized vital component of the TNFR2 receptor complex and provides new insights into the TNFR2 signaling, particularly its role in macrophage polarization with therapeutic implications for various inflammatory and autoimmune diseases with activation of the TNFR2/14-3-3[epsilon] antiinflammatory pathway., Introduction Rheumatoid arthritis (RA) is a common chronic autoimmune condition characterized by inflammatory joint disease (1), resulting from protracted inflammation of the synovial membrane. Macrophages are a major subset of [...]

Published
2021
Full Text
View/download PDF

129. Genome doubling shapes the evolution and prognosis of advanced cancers

Author

Bielski, Craig M., Zehir, Ahmet, Penson, Alexander V., Donoghue, Mark T. A., Chatila, Walid, Armenia, Joshua, Chang, Matthew T., Schram, Alison M., Jonsson, Philip, Bandlamudi, Chaitanya, Razavi, Pedram, Iyer, Gopa, Robson, Mark E., Stadler, Zsofia K., Schultz, Nikolaus, Baselga, Jose, Solit, David B., Hyman, David M., Berger, Michael F., and Taylor, Barry S.

Published
2018
Full Text
View/download PDF

131. Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

Author

Yip, Wesley, primary, Sjoberg, Daniel D., additional, Nogueira, Lucas M., additional, Tracey, Andrew T., additional, Alvim, Ricardo G., additional, Reisz, Peter A., additional, Demac, Quinlan, additional, Benfante, Nicole E., additional, Vanden Berg, Rand W., additional, Kim, Kwanghee, additional, Al-Ahmadie, Hikmat, additional, Lin, Oscar, additional, Bochner, Bernard H., additional, Dalbagni, Guido, additional, Donat, S. Machele, additional, Pietzak, Eugene J., additional, Hakimi, A. Ari, additional, Solit, David B., additional, Scherz, Avigdor, additional, Bajorin, Dean F., additional, and Coleman, Jonathan A., additional

Published
2023
Full Text
View/download PDF

133. Abstract 472: HER2 as a therapeutic target in bladder cancer

Author

Tang, Xinran, primary, Chen, Ziyu, additional, Thomas, Jasmine, additional, Nagar, Karan, additional, Christin, John, additional, Rustgi, Naryan, additional, Gao, Sizhi, additional, Chu, Carissa, additional, De Stanchina, Elisa, additional, Berger, Michael F., additional, Coleman, Jonathan A., additional, Shen, Michael M., additional, Al-Ahmadie, Hikmat A., additional, Iyer, Gopakumar V., additional, Kim, Kwanghee, additional, and Solit, David B., additional

Published
2023
Full Text
View/download PDF

134. Supplementary Table from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Author

Rappold, Phillip M., primary, Vuong, Lynda, primary, Leibold, Josef, primary, Chakiryan, Nicholas H., primary, Curry, Michael, primary, Kuo, Fengshen, primary, Sabio, Erich, primary, Jiang, Hui, primary, Nixon, Briana G., primary, Liu, Ming, primary, Berglund, Anders E., primary, Silagy, Andrew W., primary, Mascareno, Eduardo A., primary, Golkaram, Mahdi, primary, Marker, Mahtab, primary, Reising, Albert, primary, Savchenko, Alexander, primary, Millholland, John, primary, Chen, Ying-Bei, primary, Russo, Paul, primary, Coleman, Jonathan, primary, Reznik, Ed, primary, Manley, Brandon J., primary, Ostrovnaya, Irina, primary, Makarov, Vladimir, primary, DiNatale, Renzo G., primary, Blum, Kyle A., primary, Ma, Xiaoxiao, primary, Chowell, Diego, primary, Li, Ming O., primary, Solit, David B., primary, Lowe, Scott W., primary, Chan, Timothy A., primary, Motzer, Robert J., primary, Voss, Martin H., primary, and Hakimi, A. Ari, primary

Published
2023
Full Text
View/download PDF

135. Abstract 2: Vertical MAPK pathway targeting in novel genetically engineered mouse and cell line models of NF1-altered melanoma: the mSK-Mel murine cohort

Author

Jones, Alexis M., primary, Hanrahan, Aphrothiti J., additional, Nissan, Moriah H., additional, Monette, Sebastien, additional, Chen, Ziyu, additional, Hu, Wenhuo, additional, Misale, Sandra, additional, Schulze, Isabell, additional, Vasani, Naresh, additional, Liu, Cailian, additional, Yang, Xia, additional, Abu-Akeel, Mohsen, additional, de Stanchina, Elisa, additional, Schultz, Nikolaus, additional, Berger, Michael F., additional, Rosen, Neal, additional, Merghoub, Taha, additional, and Solit, David B., additional

Published
2023
Full Text
View/download PDF

136. Supplementary Figure from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

Author

Arora, Kanika, primary, Tran, Thinh N., primary, Kemel, Yelena, primary, Mehine, Miika, primary, Liu, Ying L., primary, Nandakumar, Subhiksha, primary, Smith, Shaleigh A., primary, Brannon, A. Rose, primary, Ostrovnaya, Irina, primary, Stopsack, Konrad H., primary, Razavi, Pedram, primary, Safonov, Anton, primary, Rizvi, Hira A., primary, Hellmann, Matthew D., primary, Vijai, Joseph, primary, Reynolds, Thomas C., primary, Fagin, James A., primary, Carrot-Zhang, Jian, primary, Offit, Kenneth, primary, Solit, David B., primary, Ladanyi, Marc, primary, Schultz, Nikolaus, primary, Zehir, Ahmet, primary, Brown, Carol L., primary, Stadler, Zsofia K., primary, Chakravarty, Debyani, primary, Bandlamudi, Chaitanya, primary, and Berger, Michael F., primary

Published
2023
Full Text
View/download PDF

137. Supplementary Data from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

Author

Arora, Kanika, primary, Tran, Thinh N., primary, Kemel, Yelena, primary, Mehine, Miika, primary, Liu, Ying L., primary, Nandakumar, Subhiksha, primary, Smith, Shaleigh A., primary, Brannon, A. Rose, primary, Ostrovnaya, Irina, primary, Stopsack, Konrad H., primary, Razavi, Pedram, primary, Safonov, Anton, primary, Rizvi, Hira A., primary, Hellmann, Matthew D., primary, Vijai, Joseph, primary, Reynolds, Thomas C., primary, Fagin, James A., primary, Carrot-Zhang, Jian, primary, Offit, Kenneth, primary, Solit, David B., primary, Ladanyi, Marc, primary, Schultz, Nikolaus, primary, Zehir, Ahmet, primary, Brown, Carol L., primary, Stadler, Zsofia K., primary, Chakravarty, Debyani, primary, Bandlamudi, Chaitanya, primary, and Berger, Michael F., primary

Published
2023
Full Text
View/download PDF

138. Data from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

Author

Arora, Kanika, primary, Tran, Thinh N., primary, Kemel, Yelena, primary, Mehine, Miika, primary, Liu, Ying L., primary, Nandakumar, Subhiksha, primary, Smith, Shaleigh A., primary, Brannon, A. Rose, primary, Ostrovnaya, Irina, primary, Stopsack, Konrad H., primary, Razavi, Pedram, primary, Safonov, Anton, primary, Rizvi, Hira A., primary, Hellmann, Matthew D., primary, Vijai, Joseph, primary, Reynolds, Thomas C., primary, Fagin, James A., primary, Carrot-Zhang, Jian, primary, Offit, Kenneth, primary, Solit, David B., primary, Ladanyi, Marc, primary, Schultz, Nikolaus, primary, Zehir, Ahmet, primary, Brown, Carol L., primary, Stadler, Zsofia K., primary, Chakravarty, Debyani, primary, Bandlamudi, Chaitanya, primary, and Berger, Michael F., primary

Published
2023
Full Text
View/download PDF

139. Abstract 1053: Circulating tumor DNA from cerebrospinal fluid (CSF) allows for characterization and monitoring of glioma patients

Author

Nandakumar, Subhiksha, primary, Kreitzer, Christoph, additional, Hertz, Charli Ann, additional, Rafailov, Johnathan, additional, Song, Timothy, additional, Socci, Nicholas D., additional, Brannon, A. Rose, additional, Arcila, Maria E., additional, Solit, David B., additional, Berger, Michael F., additional, Schultz, Nikolaus, additional, Mellinghoff, Ingo K., additional, and Miller, Alexandra M., additional

Published
2023
Full Text
View/download PDF

140. Supplementary Table 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

141. Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer

Author

Owczarek, Tomasz B., primary, Kobayashi, Takashi, additional, Ramirez, Ricardo, additional, Rong, Lijie, additional, Puzio-Kuter, Anna M., additional, Iyer, Gopa, additional, Teo, Min Yuen, additional, Sánchez-Vega, Francisco, additional, Wang, Jingqiang, additional, Schultz, Nikolaus, additional, Zheng, Tian, additional, Solit, David B., additional, Al-Ahmadie, Hikmat A., additional, and Abate-Shen, Cory, additional

Published
2023
Full Text
View/download PDF

142. Supplementary Figure from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Author

Rappold, Phillip M., primary, Vuong, Lynda, primary, Leibold, Josef, primary, Chakiryan, Nicholas H., primary, Curry, Michael, primary, Kuo, Fengshen, primary, Sabio, Erich, primary, Jiang, Hui, primary, Nixon, Briana G., primary, Liu, Ming, primary, Berglund, Anders E., primary, Silagy, Andrew W., primary, Mascareno, Eduardo A., primary, Golkaram, Mahdi, primary, Marker, Mahtab, primary, Reising, Albert, primary, Savchenko, Alexander, primary, Millholland, John, primary, Chen, Ying-Bei, primary, Russo, Paul, primary, Coleman, Jonathan, primary, Reznik, Ed, primary, Manley, Brandon J., primary, Ostrovnaya, Irina, primary, Makarov, Vladimir, primary, DiNatale, Renzo G., primary, Blum, Kyle A., primary, Ma, Xiaoxiao, primary, Chowell, Diego, primary, Li, Ming O., primary, Solit, David B., primary, Lowe, Scott W., primary, Chan, Timothy A., primary, Motzer, Robert J., primary, Voss, Martin H., primary, and Hakimi, A. Ari, primary

Published
2023
Full Text
View/download PDF

143. Abstract 5931: Characterizing tumor heterogeneity through bulk and single cell analysis of patient derived bladder cancer models

Author

Chen, Ziyu, primary, Tang, Xinran, additional, Havasov, Eliyahu, additional, Mcpherson, Andrew, additional, Chu, Carissa, additional, Christin, John R., additional, Berger, Michael F., additional, Schultz, Nikolaus D., additional, de Stanchina, Elisa, additional, Shen, Michael M., additional, Al-Ahmadie, Hikmat, additional, Kim, Kwanghee, additional, Iyer, Gopa, additional, and Solit, David B., additional

Published
2023
Full Text
View/download PDF

144. Data from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Author

Yaeger, Rona, primary, Mezzadra, Riccardo, primary, Sinopoli, Jenna, primary, Bian, Yu, primary, Marasco, Michelangelo, primary, Kaplun, Esther, primary, Gao, Yijun, primary, Zhao, HuiYong, primary, Paula, Arnaud Da Cruz, primary, Zhu, Yingjie, primary, Perez, Almudena Chaves, primary, Chadalavada, Kalyani, primary, Tse, Edison, primary, Chowdhry, Sudhir, primary, Bowker, Sydney, primary, Chang, Qing, primary, Qeriqi, Besnik, primary, Weigelt, Britta, primary, Nanjangud, Gouri J., primary, Berger, Michael F., primary, Der-Torossian, Hirak, primary, Anderes, Kenna, primary, Socci, Nicholas D., primary, Shia, Jinru, primary, Riely, Gregory J., primary, Murciano-Goroff, Yonina R., primary, Li, Bob T., primary, Christensen, James G., primary, Reis-Filho, Jorge S., primary, Solit, David B., primary, de Stanchina, Elisa, primary, Lowe, Scott W., primary, Rosen, Neal, primary, and Misale, Sandra, primary

Published
2023
Full Text
View/download PDF

145. Data from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Author

Rappold, Phillip M., primary, Vuong, Lynda, primary, Leibold, Josef, primary, Chakiryan, Nicholas H., primary, Curry, Michael, primary, Kuo, Fengshen, primary, Sabio, Erich, primary, Jiang, Hui, primary, Nixon, Briana G., primary, Liu, Ming, primary, Berglund, Anders E., primary, Silagy, Andrew W., primary, Mascareno, Eduardo A., primary, Golkaram, Mahdi, primary, Marker, Mahtab, primary, Reising, Albert, primary, Savchenko, Alexander, primary, Millholland, John, primary, Chen, Ying-Bei, primary, Russo, Paul, primary, Coleman, Jonathan, primary, Reznik, Ed, primary, Manley, Brandon J., primary, Ostrovnaya, Irina, primary, Makarov, Vladimir, primary, DiNatale, Renzo G., primary, Blum, Kyle A., primary, Ma, Xiaoxiao, primary, Chowell, Diego, primary, Li, Ming O., primary, Solit, David B., primary, Lowe, Scott W., primary, Chan, Timothy A., primary, Motzer, Robert J., primary, Voss, Martin H., primary, and Hakimi, A. Ari, primary

Published
2023
Full Text
View/download PDF

146. Abstract 6585: OncoKB, MSK’s precision oncology knowledge base

Author

Suehnholz, Sarah P., primary, Nissan, Moriah, additional, Zhang, Hongxin, additional, Kundra, Ritika, additional, Lu, Calvin, additional, Dhaneshwar, Amanda, additional, Fernandez, Nicole, additional, Carrero, Stephanie, additional, Arcila, Maria E., additional, Ladanyi, Marc, additional, Berger, Michael F., additional, Syed, Aijazuddin, additional, Brannon, Rose, additional, Levine, Ross, additional, Dogan, Ahmet, additional, Rosen, Ezra, additional, Drilon, Alexander, additional, Solit, David B., additional, Schultz, Nikolaus, additional, and Chakravarty, Debyani, additional

Published
2023
Full Text
View/download PDF

147. Abstract 930: Treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer harboring DDR mutations

Author

Solit, David B., primary, Mettu, Niharika B., additional, McCall, Shannon J., additional, Dhawan, Mallika, additional, Bobbili, Priyanka J., additional, DerSarkissian, Maral, additional, Ivanova, Jasmina, additional, Arondekar, Bhakti, additional, Chang, Jane, additional, Niyazov, Alexander, additional, Lee, Jocelyn, additional, Huq, Risha, additional, Green, Michelle, additional, Turski, Michelle, additional, Muthukumar, Aruna, additional, Guo, Tracy, additional, Duh, Mei Sheng, additional, and Oh, William K., additional

Published
2023
Full Text
View/download PDF

148. Abstract 330: EP300 loss drives tumorigenesis in bladder cancer via activation of IL-6/JAK/STAT3 signaling

Author

Gao, Sizhi P., primary, Rodrigues, James A., additional, Sabel, Amanda R., additional, Luo, Jiaqian, additional, Ziyu, Chen, additional, Tang, Xinran, additional, Mascareno, Eduardo A., additional, Rustgi, Naryan, additional, Al-Ahmadie, Hikmat, additional, Kim, Kwanghee, additional, Pietzak, Eugene J., additional, Iyer, Gopakumar V., additional, and Solit, David B., additional

Published
2023
Full Text
View/download PDF

149. Abstract 5214: Expanding the spectrum of germline-driven cancers by leveraging population-scale targeted tumor and normal sequencing

Author

Mehine, Miika, primary, Caeser, Rebecca, additional, Kemel, Yelena, additional, Muldoon, Daniel, additional, Franch-Expósito, Sebastià, additional, Brannon, A. Rose, additional, Syed, Aijazuddin, additional, Ceyhan-Birsoy, Ozge, additional, Misyura, Maksym, additional, Terraf, Panieh, additional, Solit, David B., additional, Ladanyi, Marc, additional, Offit, Kenneth, additional, Stadler, Zsofia K., additional, Mandelker, Diana L., additional, Murciano-Goroff, Yonina R., additional, Rudin, Charles M., additional, Berger, Michael F., additional, and Bandlamudi, Chaitanya, additional

Published
2023
Full Text
View/download PDF

150. Data from Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

Author

Jordan, Emmet J., primary, Kim, Hyunjae R., primary, Arcila, Maria E., primary, Barron, David, primary, Chakravarty, Debyani, primary, Gao, JianJiong, primary, Chang, Matthew T., primary, Ni, Andy, primary, Kundra, Ritika, primary, Jonsson, Philip, primary, Jayakumaran, Gowtham, primary, Gao, Sizhi Paul, primary, Johnsen, Hannah C., primary, Hanrahan, Aphrothiti J., primary, Zehir, Ahmet, primary, Rekhtman, Natasha, primary, Ginsberg, Michelle S., primary, Li, Bob T., primary, Yu, Helena A., primary, Paik, Paul K., primary, Drilon, Alexander, primary, Hellmann, Matthew D., primary, Reales, Dalicia N., primary, Benayed, Ryma, primary, Rusch, Valerie W., primary, Kris, Mark G., primary, Chaft, Jamie E., primary, Baselga, José, primary, Taylor, Barry S., primary, Schultz, Nikolaus, primary, Rudin, Charles M., primary, Hyman, David M., primary, Berger, Michael F., primary, Solit, David B., primary, Ladanyi, Marc, primary, and Riely, Gregory J., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results